Company intelligence / Profile preview
Manuka Bioscience
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
Overview
Manuka Bioscience is a New Zealand-based botanical science company specializing in the development of high-efficacy therapeutics and cosmeceuticals derived from East Cape mānuka oil. The company leverages the potent antimicrobial and anti-inflammatory properties of mānuka oil, specifically its high β-triketone content, to target skin conditions such as eczema and impetigo. Manuka Bioscience operates a vertically integrated model through its subsidiary, Manuka Biologicals, managing the supply chain from plantation to final product. Despite its innovative pipeline and B Corp certification, the company entered receivership in early 2025.
- Therapeutic areas
- Infectious DiseasesOtherDermatology
- Modalities
- Botanical extractPlant extractEssential oil
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Manuka Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Manuka Bioscience.